Institutional Ownership
Vtv Therapeutics Inc
CUSIP 918385204CL A NEWVTVTQ1 2026
13D / 13G Filings
10
Schedule 13D/13G on record
Beneficial Filers
6
Distinct reporting persons
Largest Stake
50.3%
Max % of class reported
Institutional Holders
32
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
10 filings · latest Dec 9, 2025
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Dec 9, 2025 | Samsara Biocapital, L.P. | 13D/A | 9.9% | — | SEC |
| 2 | Nov 12, 2025 | Invus Public Equities, L.P. | 13G/A | 9.4% | 393.1K | SEC |
| 3 | Sep 25, 2025 | Samsara Biocapital, L.P. | 13D/A | 9.9% | — | SEC |
| 4 | Sep 8, 2025 | Invus Public Equities, L.P. | 13G | 10.0% | 348.1K | SEC |
| 5 | Sep 8, 2025 | Trails Edge Capital Partners, LP | 13G | 9.9% | 340.5K | SEC |
| 6 | Sep 3, 2025 | Samsara Biocapital, L.P. | 13D/A | 9.9% | — | SEC |
| 7 | Nov 12, 2024 | Fmr LLC | 13G | 7.3% | — | SEC |
| 8 | Mar 22, 2024 | Macandrews & Forbes Inc. | 13D/A | 50.3% | 1.54M | SEC |
| 9 | Mar 5, 2024 | Samsara Biocapital, L.P. | 13D | 10.4% | 265.6K | SEC |
| 10 | Mar 5, 2024 | Baker Bros. Advisors LP | 13D | 5.0% | 122.7K | SEC |
Top Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Samsara Biocapital, LLC | 298.5K | $11.84M |
| 2 | Fmr LLC | 260.4K | $10.33M |
| 3 | Millennium Management LLC | 206.3K | $8.18M |
| 4 | Siren, L.L.C. | 163.0K | $6.46M |
| 5 | Baker Bros. Advisors LP | 148.3K | $5.88M |
| 6 | Trails Edge Capital Partners, LP | 139.6K | $5.54M |
| 7 | Geode Capital Management, LLC | 32.9K | $1.31M |
| 8 | Northern Trust Corp | 18.1K | $715.9K |
| 9 | 683 Capital Management, LLC | 16.0K | $634.6K |
| 10 | Marshall Wace, LLP | 13.4K | $531.0K |